Related Topics
Durham, N.C. — Venture-backed HyperBranch Medical Technology has received approval to sell its liquid ocular bandages in the European Union.
The approval enables HyperBranch to formally launch its first product.
Investors in HyperBranch include Aurora Funds and HIG Ventures.
HyperBranch’s OcuSeal product is a liquid that provides protection for the eye following surgical or non-surgical conditions. It is bio-degradable.
The company is also developing what it calls “surgical sealants” for brain, lung and hernia procedures.
Related Items
On The Web
![[search]](http://wwwcache.wral.com/presentation/v1/images/icons/16x12/search-form-icon.gif)
Site Search
European Union Approves HyperBranch Technology
Copyright 2008 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
News Alerts to your Email & Cell Phone-
- 2009 unlikely to be a ‘breakout year,’ so conserve, says Atlanta VC
Posted at 6:35 a.m. - Scale Finance advises Charlotte-based Quaero on $24M sale
Posted at 6:17 a.m. - AMD launches Yukon platform for ultraportable computers
Posted Jan. 6 2:09 p.m. - Protecting your assets in tough economic times
Updated Jan. 6 2:01 p.m. - Start a company in 2009 – Are you nuts? Well, no.
Posted Jan. 6 1:51 p.m.
- 2009 unlikely to be a ‘breakout year,’ so conserve, says Atlanta VC
-
- Cisco joins backers for alternative to Microsoft Outlook
Posted Jan. 6 9:50 a.m. - Global slowdown could trigger a ‘freeze’ in venture financing, Intersouth partner fears
Updated Jan. 6 11:34 a.m. - Atlanta-based Indie Music rolls out popularity tool for musicians
Jan. 6, 2009 - How to survive nuclear winter? Seize the opportunity for success, says veteran S.C. exec
Jan. 5, 2009 - VentureSource: Worst venture liquidity in five years
Jan. 3, 2009
- Cisco joins backers for alternative to Microsoft Outlook
More from wrallocaltechwire.com
Market Watch
advertisement